| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.032 | 0.6 |